2023
DOI: 10.1016/j.alit.2023.05.003
|View full text |Cite
|
Sign up to set email alerts
|

Chronic urticaria and the pathogenic role of mast cells

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
2
1
1

Citation Types

0
12
0

Year Published

2023
2023
2024
2024

Publication Types

Select...
9

Relationship

1
8

Authors

Journals

citations
Cited by 34 publications
(12 citation statements)
references
References 143 publications
0
12
0
Order By: Relevance
“…Finally, there are several knowledge gaps in our understanding of MC participation in the pathogenesis of parasympathetic paraganglioma and shaping its TME: (a) MCs produce MMPs mainly MMP‐9, which play a key role in ECM degradation and are implicated in cancer invasion and metastases. Investigation of MC production of MMPs could be an interesting research theme, (b) possible association of MC subtypes or their dominancy to prognosis is still poorly described, (c) silencing or depleting MCs was not possible until the introduction of lirentelimab (binds to inhibitory receptor Siglec‐8) and barzolvolimab (also known as CDX‐0159, binds c‐KIT and its dimerization) respectively (Elieh‐Ali‐Komi et al, 2023). Considering the tumorogenic activity of MCs in some tumor types, that may be worth investigating their role after silencing or depleting them.…”
Section: Discussionmentioning
confidence: 99%
“…Finally, there are several knowledge gaps in our understanding of MC participation in the pathogenesis of parasympathetic paraganglioma and shaping its TME: (a) MCs produce MMPs mainly MMP‐9, which play a key role in ECM degradation and are implicated in cancer invasion and metastases. Investigation of MC production of MMPs could be an interesting research theme, (b) possible association of MC subtypes or their dominancy to prognosis is still poorly described, (c) silencing or depleting MCs was not possible until the introduction of lirentelimab (binds to inhibitory receptor Siglec‐8) and barzolvolimab (also known as CDX‐0159, binds c‐KIT and its dimerization) respectively (Elieh‐Ali‐Komi et al, 2023). Considering the tumorogenic activity of MCs in some tumor types, that may be worth investigating their role after silencing or depleting them.…”
Section: Discussionmentioning
confidence: 99%
“…TNF‐alpha can influence blood vessels by promoting vasodilation and increasing permeability of blood vessels. 23 In CU, the effects of TNF‐alpha on blood vessels lead to increased permeability, allowing fluid to leak from blood vessels into the surrounding tissue. This fluid leakage contributes to edema and redness commonly observed in hives or urticarial lesions.…”
Section: Discussionmentioning
confidence: 99%
“…Notably, the activation of Mas-related G protein-coupled receptor X2 (MRGPRX2) is observed in the skin MCs of patients suffering from CSU. Other pathways contributing to MC activation in CSU involve IL-33, ST2, and thymic stromal lymphopoietin (TSLP) [ 95 ]. It has been demonstrated that the amounts of IL-25, IL-33, and TSLP are elevated in the affected skin of patients with CSU, indicating the potential involvement of ILC2s in the pathological processes of CSU [ 96 ].…”
Section: Cross-talk Between Skin Mcs and Ilc2smentioning
confidence: 99%